Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 double-blind randomized trial evaluating Gou-Teng-San (GTS) for episodic migraine; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gou-Teng-San (GTS)

Snippet

Sponsor: Tsai, Chueh-Yi, MD | Conditions: Episodic Migraine | Phase 3 | Status: RECRUITING